Sign in
Taking peoplePhase 3

TMS for Exposure Therapy Resistant OCD

Key facts

Who runs it
Amsterdam UMC, location VUmc
Where
Netherlands8 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
Phase
Phase 3
People taking part
250 people, planned
Started
16 May 2022
Expected to end
1 Dec 2027
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • repetitive transcranial magnetic stimulation (rTMS)
Record updated
4 March 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • OCD as current primary diagnosis
  • Age 18 and older
  • Yale-Brown Obsessive-Compulsive Scale (YBOCS) score of 16 or higher
  • Insufficient response to state-of-the art exposure therapy with response prevention (ERP) and/or drop-out from ERP due to extreme anxiety/avoidance
  • The following comorbid disorders are allowed (as long as OCD is the current primary diagnosis): depression, other anxiety disorders, ADHD, tic/Tourette's disorder, eating disorders, personality disorders, autism spectrum disorder (when this does not dominate the clinical profile, i.e. is not main diagnosis)
  • Commitment to actively undergo intensive exposure therapy (both supervised during ERP sessions, as well as unsupervised at home)
  • Unmedicated (for at least 8 weeks) or stable dosage of psychotropic medication (for at least 8 weeks), involving serotonergic antidepressants (SSRI, SNRI, clomipramine). Other psychotropic medication that is allowed (provided dosage is stably established for at least 8 weeks): methylphenidate, mood stabilizers, antipsychotic drugs
  • Ability to participate in frequent treatment sessions (4 days/week, for 5 (or 6, or 7) weeks) at one of the 5 sites nearest to their home and/or work
  • Ability to participate in pre-treatment MRI session (for neuronavigation) at one of the 3 academic sites nearest to their home and/or work
  • Capacity for providing informed consent

Who cannot take part

  • Cochlear implant
  • Previous rTMS treatment (for blinding reasons)
  • The following comorbid disorders (current diagnosis) are not allowed: psychotic disorders, bipolar disorder, autism spectrum disorder (when this dominates the clinical profile, i.e. is diagnosed as main disorder), substance use disorder
  • (History of) epilepsy
  • OCD patients with hoarding as main symptom dimension
  • Active suicidal thoughts and intent to act on it
  • Chronic use of benzodiazepines is not allowed
  • Pregnancy
  • Extreme claustrophobia or metallic objects in or on the body, preventing from participation in MRI session
  • Space-occupying lesion on MRI

This trial is currently available in Netherlands.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

TETRO is a multi-center placebo-controlled double-blind randomized controlled trial with an intervention phase of 5-7 weeks and a follow-up phase of 12 months in 250 adult (18 years and older) OCD patients who show no/insufficient response to ERP, aiming to establish the cost-effectiveness of low frequency (1 Hz) rTMS to the pre-SMA (compared to sham rTMS to the pre-SMA) as adjuvant treatment to exposure with response prevention (ERP). The treatment consists of 4 times/week rTMS combined with ERP for at least 5 weeks (20 sessions), with optional extension phase of 1 or 2 weeks (maximum of 28 sessions in total).

The 2 groups in the trial

  • real rTMSTreatment being tested

    verum rTMS condition, 1500 continuous 1-Hz pulses to the pre-SMA

    Treatment: repetitive transcranial magnetic stimulation (rTMS)

  • sham rTMSSham treatment, for comparison

    sham rTMS condition, 1500 continuous 1-Hz pulses to the pre-SMA

    Treatment: repetitive transcranial magnetic stimulation (rTMS)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Transcranial Magnetic Stimulation (TMS) for Patients With Exposure Therapy-resistant Obsessive-compulsive Disorder (OCD): TETRO - a Multicenter Randomized Controlled Trial
Publications
Record updated
4 March 2026